Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapy

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 1, 2007, Pages 213-215

  Siebenhaar, Frank ^a   Kühn, Wolfgang ^b   Zuberbier, Torsten ^a   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Praxis for Otolaryngology and Allergy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; OMALIZUMAB;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; LABORATORY TEST; LETTER; MENIERE DISEASE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN PIGMENTATION; SYMPTOMATOLOGY; TREATMENT OUTCOME; URTICARIA PIGMENTOSA;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MASTOCYTOSIS, CUTANEOUS; MENIERE'S DISEASE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34250826484     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.05.011     Document Type: Letter

References (11)

1. Valent P. Diagnostic evaluation and classification of mastocytosis. Immunol Allergy Clin North Am 26 (2006) 515-534
2. Valent P., Akin C., Sperr W.R., Mayerhofer M., Födinger M., Fritsche-Polanz R., et al. Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 46 (2005) 35-48
3. Valent P., Horny H.-P., Escribano L., Longley B.J., Li C.Y., Schwartz L.B., et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25 (2001) 603-625
4. Saeed S.R. Diagnosis and treatment of Ménière's disease. BMJ 16 (1998) 368-372
5. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 113 (1995) 181-185
6. Maurer M., and Metz M. The status quo and quo vadis of mast cells. Exp Dermatol 14 (2005) 923-929
7. Kawakami T., and Galli S.J. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2 (2002) 773-786
8. Ruckenstein M.J. Immunologic aspects of Meniere's disease. Am J Otolaryngol 20 (1999) 161-165
9. Babu K.S., Arshad S.H., and Holgate S.T. Omalizumab, a novel anti-IgE therapy in allergic disorders. Expert Opin Biol Ther 1 (2001) 1049-1058
10. Chang T.W., and Shiung Y.-Y. Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 117 (2006) 1203-1212
11. Carter M.C., Robyn J.A., Bressler P.B., Walker J.C., Shapiro G.G., and Metcalfe D.D. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis. J Allergy Clin Immunol 119 (2007) 1550-1551